1. Home
  2. XLO vs FOXX Comparison

XLO vs FOXX Comparison

Compare XLO & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • FOXX
  • Stock Information
  • Founded
  • XLO 2016
  • FOXX 2017
  • Country
  • XLO United States
  • FOXX United States
  • Employees
  • XLO N/A
  • FOXX N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • FOXX
  • Sector
  • XLO Health Care
  • FOXX
  • Exchange
  • XLO Nasdaq
  • FOXX Nasdaq
  • Market Cap
  • XLO 35.7M
  • FOXX 33.2M
  • IPO Year
  • XLO 2021
  • FOXX N/A
  • Fundamental
  • Price
  • XLO $0.81
  • FOXX $4.24
  • Analyst Decision
  • XLO Buy
  • FOXX
  • Analyst Count
  • XLO 2
  • FOXX 0
  • Target Price
  • XLO $3.00
  • FOXX N/A
  • AVG Volume (30 Days)
  • XLO 453.9K
  • FOXX 29.0K
  • Earning Date
  • XLO 11-06-2025
  • FOXX 11-18-2025
  • Dividend Yield
  • XLO N/A
  • FOXX N/A
  • EPS Growth
  • XLO N/A
  • FOXX N/A
  • EPS
  • XLO N/A
  • FOXX N/A
  • Revenue
  • XLO $15,001,000.00
  • FOXX $53,866,257.00
  • Revenue This Year
  • XLO $519.70
  • FOXX N/A
  • Revenue Next Year
  • XLO $44.57
  • FOXX N/A
  • P/E Ratio
  • XLO N/A
  • FOXX N/A
  • Revenue Growth
  • XLO 536.45
  • FOXX 3899.98
  • 52 Week Low
  • XLO $0.62
  • FOXX $2.45
  • 52 Week High
  • XLO $1.70
  • FOXX $11.24
  • Technical
  • Relative Strength Index (RSI)
  • XLO 62.62
  • FOXX 30.19
  • Support Level
  • XLO $0.79
  • FOXX $4.20
  • Resistance Level
  • XLO $0.91
  • FOXX $4.51
  • Average True Range (ATR)
  • XLO 0.04
  • FOXX 0.34
  • MACD
  • XLO 0.00
  • FOXX -0.04
  • Stochastic Oscillator
  • XLO 50.46
  • FOXX 8.19

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About FOXX Foxx Development Holdings Inc. Common Stock

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.

Share on Social Networks: